Answer
An increased incidence of non-melanoma skin cancers has been observed with bendamustine-containing treatment, so periodic examination is advised.
Sources for this answer
- UK GovernmentUK Government · Reputable Web
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.